Shares of Spectral Medical Inc. (TSE:EDT – Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$1.37 and traded as high as C$1.45. Spectral Medical shares last traded at C$1.44, with a volume of 54,382 shares changing hands.
Spectral Medical Stock Up 2.9%
The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The stock has a fifty day moving average price of C$1.37 and a two-hundred day moving average price of C$1.36. The company has a market cap of C$422.52 million, a P/E ratio of -11.08 and a beta of 0.65.
Spectral Medical (TSE:EDT – Get Free Report) last posted its earnings results on Friday, May 8th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$0.89 million during the quarter. On average, research analysts expect that Spectral Medical Inc. will post -0.05 EPS for the current year.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
Read More
- Five stocks we like better than Spectral Medical
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
